Karen M. Lammers

Karen M. Lammers

Auto-generated profile, based on publicly available information

Karen M. Lammers

Department of Pediatrics, Mucosal Biology Research Center, University of Maryland School of Medicine Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2011 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ASAnna Sapone
Anna Sapone
KLKaren M Lammers
Karen M Lammers
Vincenzo CasolaroVincenzo Casolaro
Vincenzo Casolaro
MCMarcella Cammarota
Marcella Cammarota
MGMariateresa Giuliano
Mariateresa Giuliano
AFAlessio Fasano
Alessio Fasano
Background: Celiac disease (CD) is an autoimmune enteropathy triggered by the ingestion of gluten. Gluten-sensitive individuals (GS) cannot tolerate gluten and may develop gastrointestinal symptoms similar to those in CD, but the overall clinical picture is generally less severe and is not accompanied by the concurrence of tissue transglutaminase autoantibodies or autoimmune comorbidities. By studying and comparing mucosal expression of genes associated with intestinal barrier function, as well as innate and adaptive immunity in CD compared with GS, we sought to better understand the similarities and differences between these two gluten-associated disorders. Methods: CD, GS and healthy, gluten-tolerant individuals were enrolled in this study. Intestinal permeability was evaluated using a lactulose and mannitol probe, and mucosal biopsy specimens were collected to study the expression of genes involved in barrier function and immunity. Results: Unlike CD, GS is not associated with increased intestinal permeability. In fact, this was significantly reduced in GS compared with controls (P = 0.0308), paralleled by significantly increased expression of claudin (CLDN) 4 (P = 0.0286). Relative to controls, adaptive immunity markers interleukin (IL)-6 (P = 0.0124) and IL-21 (P = 0.0572) were expressed at higher levels in CD but not in GS, while expression of the innate immunity marker Toll-like receptor (TLR) 2 was increased in GS but not in CD (P = 0.0295). Finally, expression of the T-regulatory cell marker FOXP3 was significantly reduced in GS relative to controls (P = 0.0325) and CD patients (P = 0.0293). Conclusions: This study shows that the two gluten-associated disorders, CD and GS, are different clinical entities, and it contributes to the characterization of GS as a condition associated with prevalent gluten-induced activation of innate, rather than adaptive, immune responses in the absence of detectable changes in mucosal barrier function.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MFMaria Fiorentino
Maria Fiorentino
KLKaren M. Lammers
Karen M. Lammers
MLMyron M Max Levine
Myron M Max Levine
MSMarcelo B. Sztein
Marcelo B. Sztein
Alessio FasanoAlessio Fasano
Alessio Fasano
Typhoid fever, caused by S. Typhi, is responsible for approximately 200,000 deaths per year worldwide. Little information is available regarding epithelium-bacterial interactions in S. Typhi infection. We have evaluated in vitro the effects of wild-type S. Typhi, the licensed Ty21a typhoid vaccine and the leading strains CVD 908-htrA and CVD 909 vaccine candidates on intestinal barrier function and immune response. Caco2 monolayers infected with wild-type S. Typhi exhibited alterations in the organization of tight junctions, increased paracellular permeability, and a rapid decrease in Trans-Epithelial Electrical Resistance as early as 4 h post-exposure. S. Typhi triggered the secretion of interleukin (IL)-8 and IL-6. Caco2 cells infected with the attenuated strains exhibited a milder pro-inflammatory response with minimal disruption of the barrier integrity. We conclude that wild-type S. Typhi causes marked transient alterations of the intestinal mucosa that are more pronounced than those observed with Ty21a or new generation attenuated typhoid vaccine candidates.

31 May 2009 in Gastroenterology
Verified
Journal Article
Closed access
KLKaren M. Lammers
Karen M. Lammers
SKSunaina Khandelwal
Sunaina Khandelwal
DKDebby Kryszak
Debby Kryszak
Vincenzo CasolaroVincenzo Casolaro
Vincenzo Casolaro
AFAlessio Fasano
Alessio Fasano

1 May 2012 in Gastroenterology
Verified
Journal Article
Closed access
ASAnna Sapone
Anna Sapone
MHMolly Hritzo
Molly Hritzo
Vincenzo CasolaroVincenzo Casolaro
Vincenzo Casolaro
DKDebby Kryszak
Debby Kryszak
SCSomaera Choudhary
Somaera Choudhary
AFAlessio Fasano
Alessio Fasano

31 May 2009 in Gastroenterology
Verified
Journal Article
Closed access
ASAnna Sapone
Anna Sapone
MGMaria Teresa Giuliano
Maria Teresa Giuliano
MCMarcella Cammarota
Marcella Cammarota
MRMario De Rosa
Mario De Rosa
MCMaria Cartenì
Maria Cartenì
AFAlessio Fasano
Alessio Fasano

1 May 2011 in Gastroenterology
Verified
Journal Article
Closed access
SKSunaina Khandelwal
Sunaina Khandelwal
MJMirkka Janka-Junttila
Mirkka Janka-Junttila
KLKaren M. Lammers
Karen M. Lammers
Marcello ChieppaMarcello Chieppa
Marcello Chieppa
EPElaine L. Leonard Puppa
Elaine L. Leonard Puppa
AFAlessio Fasano
Alessio Fasano